RESEARCH COLLABORATION

Coronavirus Research Institute (COVRI) welcomes an opportunity to form collaboration and business relationship with biopharmaceutical companies to achieve our common goals.

COVRI targets pharmaceutical markets that are not adequately served by existing therapies. The Institute focuses on antiviral drugs for the prevention and treatment of coronavirus, in addition to the development of vaccines a mass population.

In a proposed collaboration, our partners, biopharmaceutical companies would retain commercial rights to their product candidates. We will provide preclinical drug development support and clinical trials services including Phase 1,2 and 3 to reach the proof of efficacy in humans.

For further information on potential research collaboration, please contact us online at Contact Form. Thank you.